Federal Register / Vol. 87, No. 66 / Wednesday, April 6, 2022 / Notices 19937 

by calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. 

Jeffrey A. Koses, 

Senior Procurement Executive, Office of 

Acquisition Policy, Office of Governmentwide Policy. 

[FR Doc. 2022–07233 Filed 4–5–22; 8:45 am] 

BILLING CODE 6820–61–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Board on Radiation and 

Worker Health (ABRWH), 

Subcommittee on Procedures Reviews 

(SPR), National Institute for 

Occupational Safety and Health 

(NIOSH) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Subcommittee on Procedures 

Reviews (SPR) of the Advisory Board on 

Radiation and Worker Health (ABRWH 

or the Advisory Board). This meeting is 

open to the public, but without a public 

comment period. The public is welcome 

to submit written comments in advance 

of the meeting, to the contact person 

below. Written comments received in 

advance of the meeting will be included 

in the official record of the meeting. The 

public is also welcomed to listen to the 

meeting by joining the audio conference 

(information below). The audio 

conference line has 150 ports for callers. 

DATES: The meeting will be held on May 

25, 2022, from 11:00 a.m. to 3:30 p.m., 

EDT. Written comments must be 

received on or before May 18, 2022. 

ADDRESSES: You may submit comments 

by mail to: Sherri Diana, National 

Institute for Occupational Safety and 

Health, 1090 Tusculum Avenue, MS C– 

34, Cincinnati, Ohio 45226. 

Meeting Information: Audio 

Conference Call via FTS Conferencing. 

The USA toll-free dial-in number is 1– 

866–659–0537; the pass code is 

9933701. 

FOR FURTHER INFORMATION CONTACT: 

Rashaun Roberts, Ph.D., Designated 

Federal Officer, NIOSH, CDC, 1090 

Tusculum Avenue, Mailstop C–24, 

Cincinnati, Ohio 45226, Telephone: 

(513) 533–6800, Email: ocas@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines that 

have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule; advice on 

methods of dose reconstruction, which 

have also been promulgated by HHS as 

a final rule; advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program; and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort (SEC). In 

December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, 

which subsequently delegated this 

authority to CDC. NIOSH implements 

this responsibility for CDC. 

The charter was issued on August 3, 

2001, renewed at appropriate intervals, 

and rechartered under Executive Order 

13889 on March 22, 2020, and will 

terminate on March 22, 2024. 

Purpose: The Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advise the Secretary on 

whether there is a class of employees at 

any Department of Energy facility who 

were exposed to radiation but for whom 

it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. SPR 

is responsible for overseeing, tracking, 

and participating in the reviews of all 

procedures used in the dose 

reconstruction process by the NIOSH 

Division of Compensation Analysis and 

Support (DCAS) and its dose 

reconstruction contractor (Oak Ridge 

Associated Universities—ORAU). 

Matters to be Considered: The agenda 

will include discussions on the 

following: (a) Case reviews for 

Westinghouse Nuclear Fuels Division, 

Norton Company, (b) Parameters to 

Consider When Processing Claims for 

Construction Trade Workers, (c) 

Document Tracking, (d) Preparation for 

the August 2022 full ABRWH Meeting, 

and (e) Newly Issued Guidance 

Documents and Supplemental topics. 

Agenda items are subject to change as 

priorities dictate. For additional 

information, please contact Toll Free 

1(800) 232–4636. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–07248 Filed 4–5–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

RFA–CK–22–008, Building 

Mathematical Modeling Workforce 

Capacity to Support Infectious Disease 

and Healthcare Research. 

Date: July 6, 2022. 

Time: 10:00 a.m.–5:00 p.m., EDT. 

Place: Teleconference, Centers for 

Disease Control and Prevention, Room 

1080, 8 Corporate Square Boulevard, 

Atlanta, Georgia 30329–4027. 


lotter on DSK11XQN23PROD with NOTICES1
19938 Federal Register / Vol. 87, No. 66 / Wednesday, April 6, 2022 / Notices 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, CDC, National 

Center for HIV, Viral Hepatitis, STD, 

and TB Prevention, 1600 Clifton Road 

NE, Mailstop US8–1, Atlanta, Georgia 

30329–4027, Telephone: (404) 718– 

8833; Email: GAnderson@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–07246 Filed 4–5–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP)—RFA–CE22– 

012, The CDC National Centers of 

Excellence in Youth Violence 

Prevention (YVPCs): Rigorous 

Evaluation of Prevention Strategies To 

Prevent and Reduce Community Rates 

of Youth Violence; Cancellation of 

Meeting 

AGENCY: Centers for Disease Control and 

Prevention, Department of Health and 

Human Services 

ACTION: Notice. 

FOR FURTHER INFORMATION CONTACT: 

Aisha L. Wilkes, M.P.H., Scientific 

Review Officer, National Center for 

Injury Prevention and Control, CDC, 

4770 Buford Highway NE, Mailstop 

S106–9, Atlanta, Georgia 30341–3717, 

Telephone: (404) 639–6473, Email: 

AWilkes@cdc.gov. 

SUPPLEMENTARY INFORMATION: Notice is 

hereby given of a change in the meeting 

of the Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel—RFA–CE22–012, The 

CDC National Centers of Excellence in 

Youth Violence Prevention (YVPCs): 

Rigorous Evaluation of Prevention 

Strategies to Prevent and Reduce 

Community Rates of Youth Violence; 

June 21–22, 2022, 8:30 a.m.–5:30 p.m., 

EDT. 

The web conference was published in 

the Federal Register on February 1, 

2022, Volume 87, Number 21, page 

5482. 

This meeting is being canceled in its 

entirety. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–07243 Filed 4–5–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2022–0046] 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention (CDC) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting and request 

for comment. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Advisory Committee to the 

Director, Centers for Disease Control 

and Prevention (ACD, CDC). This 

meeting is open to the public. Time will 

be available for public comment. The 

meeting will be webcast live via the 

World Wide Web. 

DATES: The meeting will be held on May 

3, 2022, from 11:00 a.m. to 4:00 p.m., 

EDT (times subject to change). The 

public may submit written comments 

from April 6, 2022 through April 28, 

2022. 

ADDRESSES: You may submit comments 

identified by Docket No. CDC–2022– 

0046 by any of the following methods: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Kerry Caudwell, MPA, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–10, Atlanta, Georgia 30329–4027. 

Attn: Docket No. CDC–2022–0046. 

Instructions: All submissions received 

must include the Agency name and 

Docket Number. All relevant comments 

received in conformance with the 

https://www.regulations.gov suitability 

policy will be posted without change to 

https://www.regulations.gov, including 

any personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

https://www.regulations.gov. 

Written public comments submitted 

up to 72 hours prior to the ACD meeting 

will be provided to ACD members 

before the meeting. 

Written comments received in 

advance of the meeting will be included 

in the official record of the meeting. 

FOR FURTHER INFORMATION CONTACT: 

Kerry Caudwell, MPA, Centers for 

Disease Control and Prevention, Office 

of the Chief of Staff, 1600 Clifton Road 

NE, MS H21–10, Atlanta, Georgia 

30329–4027, Telephone: (404) 639– 

7000; Email Address: ACDirector@

cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Advisory Committee to 

the Director (ACD), CDC, shall advise 

the Secretary, HHS, and the Director, 

CDC, on policy and broad strategies that 

will enable CDC to fulfill its mission of 

protecting health through health 

promotion, prevention, and 

preparedness. The committee 

recommends ways to prioritize CDC’s 

activities, improve results, and address 

health disparities. It also provides 

guidance to help CDC work more 

effectively with its various private and 

public sector constituents to make 

health protection a practical reality. 

Matters to be Considered: The agenda 

will include discussions regarding 

CDC’s current and future work in the 

following topic areas: (1) Data 

modernization; (2) laboratory quality; 

and (3) health equity. The Advisory 

Committee to the Director (ACD) will 

consider the formation of working 

groups for each of the first two topics 

and hear a report from the existing 

health equity working group on the 

third topic. Agenda items are subject to 

change as priorities dictate. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials, are part of 

the public record and are subject to 

public disclosure. Comments will be 


lotter on DSK11XQN23PROD with NOTICES1